Accelerating New Drug Launches,
Expanding Access to Quality Medicines
Guided by our philosophy of “One Molecule, One Journey, ” and our mission of “Accelerating New Drug Launches, Expanding Access to Quality Medicines,” we leverage the collective expertise, commitment, and passion of our team to provide efficient and dependable manufacturing solutions. Our goal is to accelerate the development, regulatory approval, and global accessibility of high-quality, innovative biopharmaceuticals, ultimately benefiting patients around the world.
About
Intellective Bio (Suzhou) Co., Ltd. was founded in 2018, focusing on the development of large-molecule biopharmaceutical processes and large-scale commercialization in the CDMO field. Committed to "Accelerating New Drug Launches, Expanding Access to Quality Medicines", we provide one-stop outsourcing services for global biotechnology companies, including monoclonal antibodies, ADCs, Fc fusion proteins, etc.
Intellective Bio has completed the construction of three major production sites, with 113,400 L of installed capacity. The company operates 10 drug substance lines and 8 drug product lines, positioning itself as one of the few domestic CDMOs with core technologies, large-scale production capabilities, and end-to-end commercial manufacturing capabilities.
Corporate
Mission
Accelerating New Drug Launches,
Expanding Access to Quality Medicines
Vision
A Partner Our Clients Trust, An Employer Our People Are Proud to Fight For
